Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) Short Interest Update

Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY) was the target of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 200 shares, a decline of 80.0% from the February 28th total of 1,000 shares. Based on an average daily trading volume, of 1,300 shares, the days-to-cover ratio is currently 0.2 days.

Hikma Pharmaceuticals Trading Up 0.8 %

Shares of OTCMKTS HKMPY traded up $0.44 during trading hours on Wednesday, hitting $52.07. The stock had a trading volume of 321 shares, compared to its average volume of 909. The firm’s 50-day moving average price is $55.23 and its two-hundred day moving average price is $51.63. Hikma Pharmaceuticals has a 52 week low of $46.16 and a 52 week high of $59.26.

Hikma Pharmaceuticals Increases Dividend

The firm also recently announced a dividend, which will be paid on Monday, May 12th. Shareholders of record on Friday, March 21st will be given a $0.94 dividend. This is an increase from Hikma Pharmaceuticals’s previous dividend of $0.62. The ex-dividend date is Friday, March 21st. Hikma Pharmaceuticals’s payout ratio is currently 10.34%.

About Hikma Pharmaceuticals

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.